(LEN) Lennar - Overview
Sector: Consumer CyclicalIndustry: Residential Construction | Exchange NYSE (USA) | Currency USD | Market Cap: 22.561m | Total Return -22.1% in 12m
Stock: Residential Homes, Land Development, Rental Properties, Financial Services
Total Rating 36
Risk 83
Buy Signal -1.59
| Risk 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Relative Tail Risk | -3.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.60 |
| Alpha | -34.15 |
| Character TTM | |
|---|---|
| Beta | 0.916 |
| Beta Downside | 0.943 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.71% |
| CAGR/Max DD | 0.01 |
EPS (Earnings per Share)
Revenue
Description: LEN Lennar March 04, 2026
Lennar Corporation (LEN) is a U.S. homebuilder operating under various segments including Homebuilding East, Central, South Central, and West. The company constructs and sells single-family homes and develops residential land.
Lennar also has a financial services division, offering mortgage financing, title insurance, and closing services. This integrated approach is common among large homebuilders, providing a streamlined experience for buyers and capturing additional revenue streams.
Additionally, Lennar is involved in multifamily rental property development and management, and fund investment activities. The company targets a broad customer base, from first-time to luxury homebuyers, reflecting the diverse demand within the housing market.
To gain further insights into LENs operational metrics and financial performance, consider exploring ValueRays detailed company reports.
Headlines to watch out for
- Mortgage interest rates impact homebuyer affordability
- Land acquisition costs affect homebuilding margins
- Housing demand fluctuates with economic conditions
- Regulatory changes influence construction timelines and costs
- Multifamily segment growth diversifies revenue streams
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 1.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -6.29 > 1.0 |
| NWC/Revenue: 31.20% < 20% (prev 35.84%; Δ -4.64% < -1%) |
| CFO/TA 0.01 > 3% & CFO 216.8m > Net Income 1.79b |
| Net Debt (1.98b) to EBITDA (2.45b): 0.81 < 3 |
| Current Ratio: 4.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (244.4m) vs 12m ago -6.96% < -2% |
| Gross Margin: 16.77% > 18% (prev 0.22%; Δ 1.66k% > 0.5%) |
| Asset Turnover: 97.18% > 50% (prev 102.3%; Δ -5.17% > 0%) |
| Interest Coverage Ratio: 10.65 > 6 (EBITDA TTM 2.45b / Interest Expense TTM 198.7m) |
Altman Z'' 6.80
| A: 0.31 (Total Current Assets 13.52b - Total Current Liabilities 3.19b) / Total Assets 33.21b |
| B: 0.68 (Retained Earnings 22.58b / Total Assets 33.21b) |
| C: 0.06 (EBIT TTM 2.12b / Avg Total Assets 34.10b) |
| D: 2.02 (Book Value of Equity 22.61b / Total Liabilities 11.18b) |
| Altman-Z'' Score: 6.80 = AAA |
Beneish M -2.89
| DSRI: 0.68 (Receivables 960.9m/1.53b, Revenue 33.14b/35.81b) |
| GMI: 1.31 (GM 16.77% / 21.95%) |
| AQI: 1.21 (AQ_t 0.57 / AQ_t-1 0.47) |
| SGI: 0.93 (Revenue 33.14b / 35.81b) |
| TATA: 0.05 (NI 1.79b - CFO 216.8m) / TA 33.21b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of LEN shares?
As of March 29, 2026, the stock is trading at USD 90.25 with a total of 2,648,840 shares traded.
Over the past week, the price has changed by -0.33%, over one month by -21.08%, over three months by -12.77% and over the past year by -22.14%.
Over the past week, the price has changed by -0.33%, over one month by -21.08%, over three months by -12.77% and over the past year by -22.14%.
Is LEN a buy, sell or hold?
Lennar has received a consensus analysts rating of 3.48.
Therefor, it is recommend to hold LEN.
- StrongBuy: 4
- Buy: 2
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.9 | 12.9% |
| Analysts Target Price | 101.9 | 12.9% |
LEN Fundamental Data Overview March 28, 2026
P/E Trailing = 13.1094
P/E Forward = 13.9276
P/S = 0.6801
P/B = 1.0434
P/EG = 3.1507
Revenue TTM = 33.14b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.45b USD
Long Term Debt = 6.10b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.21b USD (from shortTermDebt, last fiscal year)
Debt = 4.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 24.54b USD (22.56b + Debt 4.07b - CCE 2.09b)
Interest Coverage Ratio = 10.65 (Ebit TTM 2.12b / Interest Expense TTM 198.7m)
EV/FCF = 870.8x (Enterprise Value 24.54b / FCF TTM 28.2m)
FCF Yield = 0.11% (FCF TTM 28.2m / Enterprise Value 24.54b)
FCF Margin = 0.09% (FCF TTM 28.2m / Revenue TTM 33.14b)
Net Margin = 5.40% (Net Income TTM 1.79b / Revenue TTM 33.14b)
Gross Margin = 16.77% ((Revenue TTM 33.14b - Cost of Revenue TTM 27.58b) / Revenue TTM)
Gross Margin QoQ = 15.23% (prev 16.29%)
Tobins Q-Ratio = 0.74 (Enterprise Value 24.54b / Total Assets 33.21b)
Interest Expense / Debt = 2.76% (Interest Expense 112.2m / Debt 4.07b)
Taxrate = 22.84% (69.1m / 302.5m)
NOPAT = 1.63b (EBIT 2.12b * (1 - 22.84%))
Current Ratio = 4.25 (Total Current Assets 13.52b / Total Current Liabilities 3.19b)
Debt / Equity = 0.19 (Debt 4.07b / totalStockholderEquity, last quarter 21.88b)
Debt / EBITDA = 0.81 (Net Debt 1.98b / EBITDA 2.45b)
Debt / FCF = 70.26 (Net Debt 1.98b / FCF TTM 28.2m)
Total Stockholder Equity = 22.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.24% (Net Income 1.79b / Total Assets 33.21b)
RoE = 8.04% (Net Income TTM 1.79b / Total Stockholder Equity 22.25b)
RoCE = 7.46% (EBIT 2.12b / Capital Employed (Equity 22.25b + L.T.Debt 6.10b))
RoIC = 5.93% (NOPAT 1.63b / Invested Capital 27.53b)
WACC = 8.12% (E(22.56b)/V(26.63b) * Re(9.20%) + D(4.07b)/V(26.63b) * Rd(2.76%) * (1-Tc(0.23)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.37%
[DCF] Terminal Value 74.75% ; FCFF base≈909.7m ; Y1≈746.1m ; Y5≈532.5m
[DCF] Fair Price = 35.66 (EV 9.70b - Net Debt 1.98b = Equity 7.72b / Shares 216.5m; r=8.12% [WACC]; 5y FCF grow -21.63% → 3.0% )
EPS Correlation: -70.91 | EPS CAGR: -35.25% | SUE: -0.24 | # QB: 0
Revenue Correlation: -10.45 | Revenue CAGR: -6.05% | SUE: -1.51 | # QB: 0
EPS next Quarter (2026-05-31): EPS=1.25 | Chg7d=-0.262 | Chg30d=-0.256 | Revisions Net=-7 | Analysts=10
EPS current Year (2026-11-30): EPS=6.08 | Chg7d=-0.464 | Chg30d=-0.832 | Revisions Net=-8 | Growth EPS=-24.6% | Growth Revenue=-2.1%
EPS next Year (2027-11-30): EPS=7.78 | Chg7d=-0.623 | Chg30d=-1.049 | Revisions Net=-9 | Growth EPS=+27.9% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -0.78 (1 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.6% (Discount Rate 9.2% - Earnings Yield 7.6%)
[Growth] Growth Spread = -4.9% (Analyst -3.3% - Implied 1.6%)
P/E Forward = 13.9276
P/S = 0.6801
P/B = 1.0434
P/EG = 3.1507
Revenue TTM = 33.14b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.45b USD
Long Term Debt = 6.10b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.21b USD (from shortTermDebt, last fiscal year)
Debt = 4.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 24.54b USD (22.56b + Debt 4.07b - CCE 2.09b)
Interest Coverage Ratio = 10.65 (Ebit TTM 2.12b / Interest Expense TTM 198.7m)
EV/FCF = 870.8x (Enterprise Value 24.54b / FCF TTM 28.2m)
FCF Yield = 0.11% (FCF TTM 28.2m / Enterprise Value 24.54b)
FCF Margin = 0.09% (FCF TTM 28.2m / Revenue TTM 33.14b)
Net Margin = 5.40% (Net Income TTM 1.79b / Revenue TTM 33.14b)
Gross Margin = 16.77% ((Revenue TTM 33.14b - Cost of Revenue TTM 27.58b) / Revenue TTM)
Gross Margin QoQ = 15.23% (prev 16.29%)
Tobins Q-Ratio = 0.74 (Enterprise Value 24.54b / Total Assets 33.21b)
Interest Expense / Debt = 2.76% (Interest Expense 112.2m / Debt 4.07b)
Taxrate = 22.84% (69.1m / 302.5m)
NOPAT = 1.63b (EBIT 2.12b * (1 - 22.84%))
Current Ratio = 4.25 (Total Current Assets 13.52b / Total Current Liabilities 3.19b)
Debt / Equity = 0.19 (Debt 4.07b / totalStockholderEquity, last quarter 21.88b)
Debt / EBITDA = 0.81 (Net Debt 1.98b / EBITDA 2.45b)
Debt / FCF = 70.26 (Net Debt 1.98b / FCF TTM 28.2m)
Total Stockholder Equity = 22.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.24% (Net Income 1.79b / Total Assets 33.21b)
RoE = 8.04% (Net Income TTM 1.79b / Total Stockholder Equity 22.25b)
RoCE = 7.46% (EBIT 2.12b / Capital Employed (Equity 22.25b + L.T.Debt 6.10b))
RoIC = 5.93% (NOPAT 1.63b / Invested Capital 27.53b)
WACC = 8.12% (E(22.56b)/V(26.63b) * Re(9.20%) + D(4.07b)/V(26.63b) * Rd(2.76%) * (1-Tc(0.23)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.37%
[DCF] Terminal Value 74.75% ; FCFF base≈909.7m ; Y1≈746.1m ; Y5≈532.5m
[DCF] Fair Price = 35.66 (EV 9.70b - Net Debt 1.98b = Equity 7.72b / Shares 216.5m; r=8.12% [WACC]; 5y FCF grow -21.63% → 3.0% )
EPS Correlation: -70.91 | EPS CAGR: -35.25% | SUE: -0.24 | # QB: 0
Revenue Correlation: -10.45 | Revenue CAGR: -6.05% | SUE: -1.51 | # QB: 0
EPS next Quarter (2026-05-31): EPS=1.25 | Chg7d=-0.262 | Chg30d=-0.256 | Revisions Net=-7 | Analysts=10
EPS current Year (2026-11-30): EPS=6.08 | Chg7d=-0.464 | Chg30d=-0.832 | Revisions Net=-8 | Growth EPS=-24.6% | Growth Revenue=-2.1%
EPS next Year (2027-11-30): EPS=7.78 | Chg7d=-0.623 | Chg30d=-1.049 | Revisions Net=-9 | Growth EPS=+27.9% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -0.78 (1 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.6% (Discount Rate 9.2% - Earnings Yield 7.6%)
[Growth] Growth Spread = -4.9% (Analyst -3.3% - Implied 1.6%)